insights_auto
Pse është ulur INO 16,21%?
Zhytu më thellëchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,22Â US$
arrow_downward
-16,21%(-0,24) 1D
1,25Â US$
arrow_upward
+2,81% (+0,034)bedtimeJashtë orarit
Mbyllur: 6 nĂ«n, 4:00:01 m.d., GMT-5 · USD
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për INO...
Hap
1,12Â US$
I lartë
1,27Â US$
I ulët
1,07Â US$
Kapitalizimi i tregut
125,63Â mln
VĂ«llimi mesatar
16,17Â mln
VĂ«llimi
39,46Â mln
Maksimumi 52-javor
2,72Â US$
Minimumi 52-javor
0,56Â US$
Fitimet për aksion
-1,17Â US$
Beta
1,71
Aksionet në qarkullim
103,40Â mln
Numri i punonjësve
112
Hap
1,12Â US$
I lartë
1,27Â US$
I ulët
1,07Â US$
Kapitalizimi i tregut
125,63Â mln
VĂ«llimi mesatar
16,17Â mln
VĂ«llimi
39,46Â mln
Maksimumi 52-javor
2,72Â US$
Minimumi 52-javor
0,56Â US$
Fitimet për aksion
-1,17Â US$
Beta
1,71
Aksionet në qarkullim
103,40Â mln
Numri i punonjësve
112
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
News Corp
·
2 minuta më parë
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Investing.com
·
4 orë më parë
Jefferies raises Inovio stock price target on regulatory win
Investing.com Nigeria
·
4 orë më parë
Why is Inovio Pharmaceuticals stock plunging today? By Investing.com
BigGo Finance
·
5 orë më parë
Inovio Shares Sink 25% After $75 Million Stock Sale Priced at $1.05
Profili
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Rreth Inovio Pharmaceuticals Inc
Drejtori ekzekutivJacqueline Shea
Punonjësit112
Themeluar më1999
Selia-
SektoriHealth Care
Industria-
Uebsajtiinovio.com